Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of the study is to determine whether combined cataract and glaucoma surgery (phacotrabeculotomy)is more effective in lowering intraocular pressure than cataract surgery alone in patients with borderline control of intraocular pressure.
Condition or disease
Primary Open Angle GlaucomaPseudoexfoliative Glaucoma
Procedure: Phacoemulsification, implantation of intraocular lensProcedure: Phacoemulsification, Implantation of IOL, trabeculotomy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Clinical Diagnosis of Primary Open Angle or Pseudoexfoliative Glaucoma and Cataract
Other glaucoma than POAG or PEX-Glaucoma
Medically uncontrolled Glaucoma:
IOP > 24 mmHg with two topical medications IOP > 21 mmHg with three topical medications
IOP < 18 mmHg with two topical medications IOP < 16 mmHg with three topical medications